← Back to Search

ADAPT for Preventing Disorders in Adopted Children (ADAPT Trial)

N/A
Waitlist Available
Led By Jeanne Miranda, Ph.D.
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Children being adopted from foster care, ages 5-14
Children (within above age range) who have been adopted in the last three years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0 weeks, 24 weeks, 36 weeks
Awards & highlights

ADAPT Trial Summary

This study seeks to pilot a manualized adoption-specific intervention aimed at providing a preventive intervention for families adopting children ages 5-14 years where family reunification has been terminated and the family is moving toward adoption or who have adopted children from foster care in the last three years. This work will fill a major gap in services to children and families and is developed to improve mental health and family functioning of children adopted from foster care, as well as decrease adoption disruptions. President Clinton's 1997 adoption initiative, The Adoption and Safe Families ACT (ASFA), along with subsequent Congressional initiatives, have provided incentives to States and subsidies for adopting older children with a resultant increase in rates of adoption from foster care from 26,000 in 1995 to 53,000 (stabilized annual rate) beginning in 2002. The mean age at adoption from foster care is now 6 years old. These older children have histories of physical and sexual abuse, neglect, and multiple placements, all factors that predict behavior problems over time. To address this gap in our knowledge of providing care for this vulnerable group, we have developed a manualized adoption-specific intervention for families adopting children from foster care. Because adoptive children generally enter homes with stable, well-functioning parents, interventions may be particularly effective in helping the children adjust and their parents learn to understand and manage children with difficult past histories. The aim of this current pilot trial is to test this intervention designed to improve the outcomes for children adopted from foster care through a randomized trial. Our hypothesis is that this manualized adoption-specific intervention will be more effective than care as usual in improving child mental health and family functioning outcomes; specifically, families and children who have been randomized to the manualized adoption-specific intervention will show better outcomes on the post-treatment measures and the 3 month follow-up than on the pre-treatment measures than the care as usual families and children.

ADAPT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

ADAPT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0 weeks, 24 weeks, 36 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0 weeks, 24 weeks, 36 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Parent Weekly Report
Secondary outcome measures
Number of child participants whose internalizing and externalizing behaviors improve

ADAPT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ADAPTExperimental Treatment1 Intervention
ADAPT is a manualized intervention with eight treatment modules designed as an early intervention for children, ages 5-14, who are being adopted from foster care and their adoptive parent/s.
Group II: Care as usualActive Control1 Intervention
Children, ages 5-14, and their adoptive parent/s will receive care as usual in the treatment setting.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ADAPT
2015
N/A
~530

Find a Location

Who is running the clinical trial?

Center for Adoption Support and EducationUNKNOWN
University of California, Los AngelesLead Sponsor
1,528 Previous Clinical Trials
10,276,791 Total Patients Enrolled
Jeanne Miranda, Ph.D.Principal InvestigatorUniversity of California, Los Angeles

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Apr 2025